why choose us

First received: December 12, 2022

Clinical Trial: A Phase I Trial Evaluate the Safety and Tolerability Profile of HPV Vaccine

Study Status: Completed

Recruit Status: Completed

Condition: Human Papillomavirus Infection

Study Type: Interventional


Official Title: A Phase I Trial in Healthy Chinese Women Ages 18-45 to Evaluate the Safety and Tolerability Profile of Recombinant Nonavalent (Types 6/11/16/18/31/33/45/52/58) Human Papillomavirus (HPV) Vaccine (Esch

Brief Summary: This study is to evaluate the safety and tolerability profile of Recombinant Nonavalent (Types 6/11/16/18/31/33/45/52/58) Human Papillomavirus (HPV) Vaccine (Escherichia Coli) in healthy women ages 18-45

Read more